Breaking News Instant updates and real-time market news.

BIIB

Biogen

$272.46

0.52 (0.19%)

14:03
04/21/17
04/21
14:03
04/21/17
14:03

Biogen announces positive CHMP opinion for Spinraza for SMA treatment

Biogen announced the Committee for Medicinal Products for Human Use, or CHMP, of the European Medicines Agency adopted a positive opinion recommending the granting of a marketing authorization for Spinraza to treat patients with spinal muscular atrophy, or SMA. The CHMP reviewed Spinraza under an accelerated assessment program, which is a regulatory mechanism to facilitate earlier access to patients for medicines that fulfill unmet medical needs. Spinraza is the first treatment for SMA to be recommended by the CHMP for approval in the European Union, the company said.

  • 24

    Apr

  • 25

    Apr

BIIB Biogen
$272.46

0.52 (0.19%)

04/04/17
SBSH
04/04/17
NO CHANGE
Target $315
SBSH
Buy
Citi reiterates Buy on Biogen after SMA survey
Citi analyst Robyn Karnauskas says her follow-up spinal muscular atrophy survey supports her 2017 thesis on Biogen. The survey, with same doctors to assess the progress of Biogen's Spinraza launch, suggests 11% of the SMA patients have already started on the drug, Karnauskas tells investors in a research note. 18% of the patients have been prescribed Spinraza, up from 10% in the analyst's last survey in January. Karnauskas believes the Q1 consensus of $20M in Spinraza revenue looks achievable. She keeps a Buy rating on Biogen with a $315 price target.
04/04/17
JMPS
04/04/17
DOWNGRADE
JMPS
Market Perform
Forward Pharma downgraded on patent loss at JMP Securities
As noted earlier, JMP Securities downgraded Forward Pharma to Market Perform from Outperform. Analyst Jason Butler downgraded the stock after the Patent Trial and Appeal Board of the United States Patent and Trademark Office decided that all the company's '187 patent claims against Biogen (BIIB) are invalid. Butler believes that Forward's stock is fairly valued at current levels.
04/07/17
LEER
04/07/17
NO CHANGE
Target $290
LEER
Market Perform
Biogen price target lowered to $290 from $300 at Leerink
Leerink analyst Geoffrey Porges lowered his price target for Biogen (BIIB) to $290 from $300 on valuation and reiterated a Market Perform rating on the shares. Last week, the FDA granted approval to its competitor Roche's (RHHBY) Ocrevus for the treatment of both relapsing remitting multiple sclerosis and primary progressive multiple sclerosis, the analyst points out, adding that he believes Ocrevus will be a "game changer" in multiple sclerosis treatment.
04/11/17
CHDN
04/11/17
NO CHANGE
Target $50
CHDN
Buy
REGENXBIO price target raised to $50 from $35 at Chardan
Chardan analyst Gbola Amusa raised his price target on REGENXBIO (RGNX) to $50 from $35, calling the company's appointment of Olivier Danos from Biogen (BIIB) as Chief Scientific Officer a "watershed moment" that increases his conviction in the company's long-term prospects. Amusa keeps a Buy rating on REGENXBIO shares.

TODAY'S FREE FLY STORIES

PYPL

PayPal

$44.41

-0.3 (-0.67%)

09:06
04/27/17
04/27
09:06
04/27/17
09:06
Recommendations
PayPal analyst commentary  »

PayPal margins have…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

  • 20

    Jun

  • 21

    Jun

  • 22

    Jun

  • 22

    Jun

NOVN

Novan

$5.45

0.06 (1.11%)

09:06
04/27/17
04/27
09:06
04/27/17
09:06
Hot Stocks
Novan presents preclinical data from inflammatory skin diseases program »

Novan announced that data…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JAZZ

Jazz Pharmaceuticals

$157.75

2.85 (1.84%)

09:06
04/27/17
04/27
09:06
04/27/17
09:06
Recommendations
Jazz Pharmaceuticals analyst commentary  »

Jazz Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    May

HTM

U.S. Geothermal

$4.17

0.04 (0.97%)

09:05
04/27/17
04/27
09:05
04/27/17
09:05
Hot Stocks
U.S. Geothermal provides update on Raft River expansion program »

U.S. Geothermal provided…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STX

Seagate

$42.01

-8.5 (-16.83%)

09:05
04/27/17
04/27
09:05
04/27/17
09:05
Recommendations
Seagate analyst commentary  »

Seagate selloff following…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Jun

09:05
04/27/17
04/27
09:05
04/27/17
09:05
General news
U.S. durable goods orders rose 0.7% in March »

U.S. durable goods orders…

ORI

Old Republic

$20.22

0.15 (0.75%)

09:04
04/27/17
04/27
09:04
04/27/17
09:04
Earnings
Old Republic reports Q1 EPS 39c, consensus 31c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

F

Ford

$11.60

0.12 (1.05%)

09:04
04/27/17
04/27
09:04
04/27/17
09:04
Hot Stocks
Ford says 'fit' for any future downturn in North America »

Comments taken from the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 02

    May

UPS

UPS

$107.62

0.26 (0.24%)

09:04
04/27/17
04/27
09:04
04/27/17
09:04
Hot Stocks
Breaking Hot Stocks news story on UPS »

UPS says Q1 pricing in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 04

    May

  • 16

    May

  • 17

    May

  • 18

    May

  • 19

    May

  • 31

    May

ANTM

Anthem

$179.03

6.57 (3.81%)

, CVS

CVS Health

$82.00

-0.17 (-0.21%)

09:03
04/27/17
04/27
09:03
04/27/17
09:03
Recommendations
Anthem, CVS Health, Express Scripts analyst commentary  »

Anthem price target…

ANTM

Anthem

$179.03

6.57 (3.81%)

CVS

CVS Health

$82.00

-0.17 (-0.21%)

ESRX

Express Scripts

$61.28

1.27 (2.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

  • 10

    May

  • 18

    May

  • 06

    Jun

CBS

CBS

$66.91

0.5 (0.75%)

09:03
04/27/17
04/27
09:03
04/27/17
09:03
Recommendations
CBS analyst commentary  »

CBS valuation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 04

    May

  • 08

    May

  • 15

    Jun

GRUB

GrubHub

$35.02

0.24 (0.69%)

09:03
04/27/17
04/27
09:03
04/27/17
09:03
Earnings
GrubHub sees FY17 revenue $632M-$662M, consensus $644.39M »

Sees FY17 adjusted EBITDA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 11

    May

  • 24

    May

  • 25

    May

BANC

Banc of California

$22.45

-0.15 (-0.66%)

09:03
04/27/17
04/27
09:03
04/27/17
09:03
Hot Stocks
Banc of California names Doug Bowers as CEO, effective May 8 »

Banc of California…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jun

ORRF

Orrstown Financial

$21.95

-0.45 (-2.01%)

09:03
04/27/17
04/27
09:03
04/27/17
09:03
Earnings
Orrstown Financial reports Q1 EPS 24c, consensus 20c »

Net interest income…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

GRUB

GrubHub

$35.02

0.24 (0.69%)

09:02
04/27/17
04/27
09:02
04/27/17
09:02
Earnings
GrubHub sees Q2 revenue $153M-$161M, consensus $157.95M »

Sees Q2 adjusted EBITDA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 11

    May

  • 24

    May

  • 25

    May

GRUB

GrubHub

$35.02

0.24 (0.69%)

09:01
04/27/17
04/27
09:01
04/27/17
09:01
Earnings
GrubHub reports Q1 non-GAAP EPS 29c, consensus 24c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 11

    May

  • 24

    May

  • 25

    May

DISCA

Discovery

$29.39

0.1 (0.34%)

09:00
04/27/17
04/27
09:00
04/27/17
09:00
Periodicals
Discovery Asia partners with VS Media, Tabilabo, Variety says »

Discovery Networks Asia…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 08

    May

  • 18

    May

  • 31

    May

CNMD

CONMED

$48.13

0.93 (1.97%)

09:00
04/27/17
04/27
09:00
04/27/17
09:00
Recommendations
CONMED analyst commentary  »

CONMED price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

  • 24

    May

UA

Under Armour

$18.14

0.17 (0.95%)

, UAA

Under Armour

$19.71

0.18 (0.92%)

09:00
04/27/17
04/27
09:00
04/27/17
09:00
Hot Stocks
Under Armour CFO sees Q4 to be strongest comparison of 2017 'by far' »

Under Armour CFO David…

UA

Under Armour

$18.14

0.17 (0.95%)

UAA

Under Armour

$19.71

0.18 (0.92%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 31

    May

09:00
04/27/17
04/27
09:00
04/27/17
09:00
General news
U.S. Advance trade deficit in goods widened slightly to -$64.8 B »

U.S. Advance trade…

SNCR

Synchronoss

$24.62

-0.02 (-0.08%)

09:00
04/27/17
04/27
09:00
04/27/17
09:00
Hot Stocks
Breaking Hot Stocks news story on Synchronoss »

Synchronoss trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    May

BGSF

BG Staffing

$15.15

-0.27 (-1.75%)

08:58
04/27/17
04/27
08:58
04/27/17
08:58
Earnings
BG Staffing reports Q1 EPS 15c, consensus 12c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 02

    May

TMO

Thermo Fisher

$168.01

9.2 (5.79%)

08:58
04/27/17
04/27
08:58
04/27/17
08:58
Recommendations
Thermo Fisher analyst commentary  »

Thermo Fisher price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    May

  • 06

    Jun

SNBC

Sun Bancorp

$25.70

-0.05 (-0.19%)

08:57
04/27/17
04/27
08:57
04/27/17
08:57
Earnings
Sun Bancorp reports Q1 EPS 7c, consensus 8c »

Reports Q1 NII $14.78M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 15

    May

UPS

UPS

$107.62

0.26 (0.24%)

08:57
04/27/17
04/27
08:57
04/27/17
08:57
Hot Stocks
UPS says sees margin improvement in 2017 »

Expects revenue to grow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 04

    May

  • 16

    May

  • 17

    May

  • 18

    May

  • 19

    May

  • 31

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.